Compare Mitosis (MITO) vs Scallop (SCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitosis vs Scallop — how do they compare? Mitosis trades at Rp385.99 (market cap Rp69,57M, Rp65,35M 24h volume), while Scallop trades at Rp167.58 (market cap Rp25,16M, Rp10,98M 24h volume). The key difference: Mitosis is far larger — about 2.8× Scallop's market cap, and Mitosis's circulating supply is 181,3M / 1B MITO (19%) versus 163,5M / 250M SCA (66%) for Scallop. Which is the better fit depends on your goals — on Pluang, investors hold Mitosis for 19 Days and Scallop for 13 Days on average.
| MITO | SCA | |
|---|---|---|
Market Cap | Rp69,57M | Rp25,16M |
Volume (24h) | Rp65,35M | Rp10,98M |
Circulating Supply | 181,3M / 1B MITO (19%) | 163,5M / 250M SCA (66%) |
Typical Hold Time | 19 Days | 13 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MITO is trading at Rp385.97 with a bearish technical signal, as moving averages indicate strong selling pressure while oscillators remain neutral. The token has a market cap of Rp70.05 million and a low circulation rate of 19%, with key support at Rp352 and resistance at Rp395. Recent news highlights a corporate acquisition of a similarly named entity, but no direct protocol updates were found for the cryptocurrency.
Overall outlook is cautious due to bearish technicals and limited fundamental developments. Key opportunities include potential recovery if support holds, but risks involve low liquidity and minimal ecosystem activity. Investors should monitor for any token-specific news or network updates to reassess positioning.
Scallop (SCA) is trading at Rp168.32 with a market cap of Rp25.17 million, showing bullish technical signals despite bearish moving averages. The token has 66% of its max supply in circulation with an average hold time of 13 days. Recent ETF inclusion by GraniteShares in May 2026 provides institutional exposure, though the news articles reference equity ETFs rather than direct cryptocurrency developments.
Overall outlook is cautiously optimistic with technical strength but limited fundamental catalysts. Key opportunities include institutional ETF exposure and neutral oscillator positioning. Major risks include high RSI_6 at 89.40 (overbought), low market cap vulnerability, and the token's relatively new market presence requiring careful risk management.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Mitosis
Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →About Scallop
Scallop is an advanced decentralized finance (DeFi) protocol built on the Sui blockchain. It offers a wide range of financial services, including lending, borrowing, automated market making (AMM), and asset management. Developed by Scallop Labs, which has a team of experts in DeFi, cybersecurity, and fintech, Scallop has attracted support from notable investors such as CMS Holdings, 6th Man Ventures, KuCoin Labs, and Mysten Labs. Additionally, it is the first DeFi project to receive an official grant from the Sui Foundation, highlighting its institutional-grade quality and strong security features.
Read more on SCA →
